URO ONCO

Welcome, this website is intended for all international healthcare professionals in uro-oncology. By clicking the link below you are declaring and confirming that you are a healthcare professional.

You are here

Interview at EMUC 2014 with Prof. Jeffrey Karnes, Rochester, USA

What is really high-risk prostate cancer? Role of biomarker and genetic assessment.

Karnes-

Genetic assessments may be based on germline information or tumor genetics. Not all high risk prostate cancers are equal and genetics based on the radical prostatectomy may be helpful to tailor additional treatment.

E-Alert

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Subscribe

URO ONCO is made possible by an unrestricted educational grant from:

The editorial independence of the resource centre is mandatory and recognized by the EAU and Elsevier.

The journal articles, videos and statements published on the resource centre have been selected independently and without influence from Elsevier, European Urology Editors or the sponsor and do not necessarily reflect their opinions or views.